Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease

Kaori Hayashi1, Hiroshi Itoh

  • 1Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan, kaorihayashi@a3.keio.jp.

Insights

Epigenetic mechanisms, including DNA methylation and histone modification, are crucial in chronic kidney disease (CKD) progression. Targeting transcription factors offers a promising therapeutic strategy for CKD remission.

Area of Science:

  • Nephrology
  • Epigenetics
  • Molecular Biology

Background:

  • Emerging evidence implicates epigenetic mechanisms in the initiation and progression of various diseases, including kidney diseases.
  • Chronic kidney disease (CKD) and kidney fibrosis are complex conditions influenced by epigenetic factors.
  • Understanding these mechanisms is vital for developing novel therapeutic strategies.

Purpose of the Study:

  • To review current data on epigenetic modulation in CKD and kidney fibrosis.
  • To explore the role of transcription factors in epigenetic regulation within the kidney.
  • To assess the therapeutic potential of targeting epigenetic modifications for CKD treatment.

Main Methods:

  • Review of existing literature on epigenetic mechanisms in kidney disease.
  • Focus on DNA methylation and histone modification.
  • Analysis of the role of specific transcription factors, such as Kruppel-like factor 4 (KLF4).

Main Results:

  • Epigenetic modulation, including DNA methylation and histone modification, plays a significant role in CKD and kidney fibrosis.
  • Transcription factors are key regulators of epigenetic processes in kidney cells.
  • Kruppel-like factor 4 (KLF4) is expressed in kidney podocytes and influences their phenotype through epigenetic control.

Conclusions:

  • Targeting transcription factors for epigenetic modification presents a potential therapeutic avenue for CKD remission and regression.
  • Organ-, tissue-, and gene-specific epigenetic-based therapies are necessary to minimize side effects in CKD treatment.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
662
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.6K
Epigenetic Regulation01:46

Epigenetic Regulation

26.8K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.7K